Hussein El Hajj

Dr. Hussein El Hajj

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2022 in Management Science
Verified
Journal Article
Closed access
HHHussein El Hajj
Hussein El Hajj
DBDouglas R. Bish
Douglas R. Bish
EBEbru K. Bish
Ebru K. Bish
DKDenise M. Kay
Denise M. Kay
Newborn screening (NBS) is a state-level initiative that detects life-threatening genetic disorders for which early treatment can substantially improve health outcomes. Cystic fibrosis (CF) is among the most prevalent disorders in NBS. CF can be caused by a large number of mutation variants to the CFTR gene. Most states use a multitest CF screening process that includes a genetic test (DNA). However, due to cost concerns, DNA is used only on a small subset of newborns (based on a low-cost biomarker test with low classification accuracy), and only for a small subset of CF-causing variants. To overcome the cost barriers of expanded genetic testing, we explore a novel approach, of multipanel pooled DNA testing. This approach leads not only to a novel optimization problem (variant selection for screening, variant partition into multipanels, and pool size determination for each panel), but also to novel CF NBS processes. We establish key structural properties of optimal multipanel pooled DNA designs; develop a methodology that generates a family of optimal designs at different costs; and characterize the conditions under which a 1-panel versus a multipanel design is optimal. This methodology can assist decision-makers to design a screening process, considering the cost versus accuracy trade-off. Our case study, based on published CF NBS data from the state of New York, indicates that the multipanel and pooling aspects of genetic testing work synergistically, and the proposed NBS processes have the potential to substantially improve both the efficiency and accuracy of current practices. This paper was accepted by Stefan Scholtes, healthcare management. Funding: This work was supported by National Science Foundation [Grant 1761842]. Any opinion, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. Supplemental Material: The data files and e-companion are available at https://doi.org/10.1287/mnsc.2021.4289 .

1 January 2024 in Manufacturing & Service Operations Management
Verified
Journal Article
Closed access
DBDouglas R. Bish
Douglas R. Bish
EBEbru K. Bish
Ebru K. Bish
HHHussein El Hajj
Hussein El Hajj
Problem definition: Infectious disease screening can be expensive and capacity constrained. We develop cost- and capacity-efficient testing designs for multidisease screening, considering (1) multiplexing (disease bundling), where one assay detects multiple diseases using the same specimen (e.g., nasal swabs, blood), and (2) pooling (specimen bundling), where one assay is used on specimens from multiple subjects bundled in a testing pool. A testing design specifies an assay portfolio (mix of single-disease/multiplex assays) and a testing method (pooling/individual testing per assay). Methodology/results: We develop novel models for the nonlinear, combinatorial multidisease testing design problem: a deterministic model and a distribution-free, robust variation, which both generate Pareto frontiers for cost- and capacity-efficient designs. We characterize structural properties of optimal designs, formulate the deterministic counterpart of the robust model, and conduct a case study of respiratory diseases (including coronavirus disease 2019) with overlapping clinical presentation. Managerial implications: Key drivers of optimal designs include the assay cost function, the tester’s preference toward cost versus capacity efficiency, prevalence/coinfection rates, and for the robust model, prevalence uncertainty. When an optimal design uses multiple assays, it does so in conjunction with pooling, and it uses individual testing for at most one assay. Although prevalence uncertainty can be a design hurdle, especially for emerging or seasonal diseases, the integration of multiplexing and pooling, and the ordered partition property of optimal designs (under certain coinfection structures) serve to make the design more structurally robust to uncertainty. The robust model further increases robustness, and it is also practical as it needs only an uncertainty set around each disease prevalence. Our Pareto designs demonstrate the cost versus capacity trade-off and show that multiplexing-only or pooling-only designs need not be on the Pareto frontier. Our case study illustrates the benefits of optimally integrated designs over current practices and indicates a low price of robustness.Funding: This work was supported by the National Science Foundation [Grant 1761842].Supplemental Material: The online appendix is available at https://doi.org/10.1287/msom.2022.0296 .

1 January 2022 in Operations Research
Verified
Journal Article
Closed access
HHHussein El Hajj
Hussein El Hajj
DBDouglas R. Bish
Douglas R. Bish
EBEbru K. Bish
Ebru K. Bish
Improving Newborn Screening for Genetic DiseasesScreening newborns for life-threatening genetic diseases is an important public health initiative. Cystic fibrosis is one of the most prevalent diseases in this context. As part of the cystic fibrosis screening process, all states in the United States use multiple tests, including genetic tests that detect a subset of the more than 300 genetic variants (specific mutations) that cause cystic fibrosis. In “Optimal Genetic Screening for Cystic Fibrosis,” El-Hajj, D.R. Bish, and E.K. Bish develop a decision support model to select which genetic variants to screen for, considering the trade-off between classification accuracy and testing cost, and the technological constraints that limit the number of variants selected. Because variant prevalence rates are highly uncertain, a robust optimization framework is developed. Further, two commonly used cystic fibrosis screening processes are analytically compared, and conditions under which each process dominates are established. A case study based on published data are provided.

17 September 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
Marwan Shams EddinMarwan Shams Eddin
Marwan Shams Eddin
HHHussein El Hajj
Hussein El Hajj
Background: Emerging pandemics can rapidly overwhelm hospital capacity, leading to increased mortality and healthcare costs. Objective: We develop an optimization-based framework that dynamically schedules hospital beds across multiple facilities to minimize total healthcare costs, including patient rejections and logistical expenses, under resource constraints. Methods: The model integrates several real-world flexibilities: standard hospital beds, buffer capacity from non-pandemic wards, in situ field hospitals, and inter-hospital patient transfers. To capture demand uncertainty, we link the model with an SEIRD epidemic forecasting approach and further extend it with a robust optimization variant that safeguards against worst-case surges. Recognizing computational challenges, we reformulate the problem to significantly reduce solution times and derive structural properties that provide guidance on when to open field hospitals, allocate buffer beds, and prioritize patients across facilities. Results: A case study based on COVID-19 data from Northern Virginia shows that the proposed framework reduces healthcare costs by more than 50% compared with current practice, mainly by lowering patient rejection rates. Conclusions: These results highlight the value of combining epidemic forecasting with prescriptive optimization to improve resilience and inform healthcare policy during crises.

8 July 2025 in Epidemiologia
Verified
Journal Article
Open access
PDF file
Marwan Shams EddinMarwan Shams Eddin
Marwan Shams Eddin
HHHussein El Hajj
Hussein El Hajj
RZRamez Mohammad Zayyat
Ramez Mohammad Zayyat
GLGayeon Lee
Gayeon Lee
Background/Objectives: The COVID-19 pandemic highlighted the critical need for accurate predictive models to guide public health interventions and optimize healthcare resource allocation. This study evaluates how the complexity of compartmental infectious disease models influences their forecasting accuracy and utility for pandemic resource planning. Methods: We analyzed a range of compartmental models, including simple susceptible-infected-recovered (SIR) models and more complex frameworks incorporating asymptomatic carriers and deaths. These models were calibrated and tested using real-world COVID-19 data from the United States to assess their performance in predicting symptomatic and asymptomatic infection counts, peak infection timing, and resource demands. Both adaptive models (updating parameters with real-time data) and non-adaptive models were evaluated. Results: Numerical results show that while more complex models capture detailed disease dynamics, simpler models often yield better forecast accuracy, especially during early pandemic stages or when predicting peak infection periods. Adaptive models provided the most accurate short-term forecasts but required substantial computational resources, making them less practical for long-term planning. Non-adaptive models produced stable long-term forecasts useful for strategic resource allocation, such as hospital bed and ICU planning. Conclusions: Model selection should align with the pandemic stage and decision-making horizon. Simpler models are effective for rapid early-stage interventions, adaptive models excel in short-term operational forecasting, and non-adaptive models remain valuable for long-term resource planning. These findings can inform policymakers on selecting appropriate modeling approaches to improve pandemic response effectiveness.

4 July 2025 in INFOR: Information Systems and Operational Research
Verified
Journal Article
Closed access
HHHussein El Hajj
Hussein El Hajj
FGFatma Gzara
Fatma Gzara
SESamir Elhedhli
Samir Elhedhli